(R)-5-Amino-2-((tert-butoxycarbonyl)amino)pentanoic acid, 95.0%, 5g

2',4'-Difluoro-4-hydroxy-biphenyl-3-carboxylic acid, 98.00%, 25g

Fmoc-Glu(OBzl)-OH, 97%, 5g

(5-Amino-2-fluorophenyl)methanol, 95.0%, 1g

(2r,4s)-1-[(tert-butoxy)carbonyl]-4-({[(9h-fluoren-9-yl)methoxy]carbonyl}amino)pyrrolidine-2-carboxylic acid, 97%, 5g

2-(Phenylsulfonamido)acetic acid, 95.0%, 1g

[(4-methyl-1,3-thiazol-2-yl)amino](oxo)acetic acid, 95.0%, 5g

GC capillary column ROTI®Cap-5, 30 m, 0.25 mm, 1.00 µm, 1 Piece(s)

Ethyl 4-chloro-[1,2,4]triazolo[4,3-a]quinoxaline-1-carboxylate, 95%, 250mg

1-Methoxy-1,3-dihydroisobenzofuran, 98%, 5g

(1,2-Phenylenebis(methylene))bis(triphenylphosphonium) bromide, 98+%, 10g

5-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 5g

7-Bromo-2,3-dichloropyrido[2,3-b]pyrazine, 98%, 100mg